海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
334件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- Everolimus added to long acting octreotide as a volume reducing treatment of polycystic livers. - ELATE
- Isolated polycystic liver disease MedDRA version: 12.1 Level: LLT Classification code 10048834 Term: Polycystic liver disease MedDRA version: 12.1 Level: PT Classification code 10048834 Term: Polycystic liver disease
- Netherlands
- 2009-12-24
Authorised
- Pilot study - sequential combination therapy using selective immunoglobulin apheresis and omalizumab in patients with severe atopic dermatitis and elevated total IgE levels
- Patients with severe Atopic dermatitis and total IgE-level > 700 IU/ml (potentially associated with bronchial asthma and/or allergic rhinitis) MedDRA version: 12.0 Level: LLT Classification code 10002198 Term: Anaphylactic reaction MedDRA version: 12.0 Level: LLT Classification code 10040400 Term: Serum sickness MedDRA version: 12.0 Level: LLT Classification code 10043554 Term: Thrombocytopenia MedDRA version: 12.0 Level: LLT Classification code 10019211 Term: Headache MedDRA version: 12.0 Level: LLT Classification code 10028810 Term: Nasopharyngitis MedDRA version: 12.0 Level: LLT Classification code 10040753 Term: Sinusitis MedDRA version: 12.0 Level: LLT Classification code 10022000 Term: Influenza MedDRA version: 12.0 Level: LLT Classification code 10006451 Term: Bronchitis MedDRA version: 12.0 Level: LLT Classification code 10017888 Term: Gastroenteritis MedDRA version: 12.0 Level: LLT Classification code 10034835 Term: Pharyngitis MedDRA version: 12.0 Level: LLT Classification code 10047461 Term: Viral infection MedDRA version: 12.0 Level: LLT Classification code 10034844 Term: Pharyngolaryngeal pain MedDRA version: 12.0 Level: LLT Classification code 10011224 Term: Cough MedDRA version: 12.0 Level: LLT Classification code 10039083 Term: Rhinitis MedDRA version: 12.0 Level: LLT Classification code 10028735 Term: Nasal congestion MedDRA version: 12.0 Level: LLT Classification code 10039085 Term: Rhinitis allergic MedDRA version: 12.0 Level: LLT Classification code 10012727 Term: Diarrhea MedDRA version: 12.0 Level: LLT Classification code 10028813 Term: Nausea MedDRA version: 12.0 Level: LLT Classification code 10013946 Term: Dyspepsia MedDRA version: 12.0 Level: LLT Classification code 10003988 Term: Back pain MedDRA version: 12.0 Level: LLT Classification code 10003239 Term: Arthralgia MedDRA version: 12.0 Level: LLT Classification code 10028411 Term:
- Germany
- 2009-10-12
Authorised
- A Phase III, randomised, double-blind, placebo-controlled parallel group efficacy and safety study of linagliptin 5 mg administered orally once daily over 24 weeks in type 2 diabetic patients with insufficient glycaemic control despite a therapy of metformin in combination with pioglitazone
- Type 2 Diabetes Mellitus MedDRA version: 12.0 Level: LLT Classification code 10067585 Term: Type 2 diabetes mellitus MedDRA version: 12.0 Level: LLT Classification code 10067585 Term: Type 2 diabetes mellitus
- France
- 2009-09-08
Authorised
- A MULTICENTER, RANDOMIZED, INTRA-INDIVIDUAL, DOUBLE BLIND, VEHICLE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CD2027 OINTMENT 9µG/G APPLIED TWICE DAILY OVER 4 WEEKS IN THE TREATMENT OF TARGET LESIONS IN ADULTS SUBJECTS WITH ATOPIC DERMATITIS.
- Atopic Dermatitis MedDRA version: 9.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis
- France, Hungary
- 2009-05-15
Authorised
- A multicenter, double-blind, randomized, 12-month, placebo-controlled study to evaluate the lipid-lowering effect, safety and tolerability of AVE5530 25 mg/day and 50mg/day when added to ongoing stable statin therapy (HMG-CoA reductase inhibitors) in patients with primary hypercholesterolemia.
- Primary Hypercholesterolemia MedDRA version: 11.0 Level: LLT Classification code 10060375 Term:
- Belgium, Czech Republic, Denmark, France, Germany, Hungary, Netherlands, Poland, Portugal, Spain, Sweden
- 2008-06-23
Authorised
- A study to determine the effects of up to 2 weeks of treatment with an ointment applied to the skin containing the drug ZPL-5212372 in healthy volunteers and adult patients with moderate to severe atopic dermatitis.
- Atopic Dermatitis MedDRA version: 18.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- United Kingdom
- 2016-03-24
Authorised
- Explorative study on the clinical efficacy and tolerability of methylprednisolone aceponate cream and a new topical medical device in paediatric patients with mild to moderate Atopic Dermatitis, testing two different application modalities in the same patient on flexural contralateral lesions.
- Atopic Dermatitis;Therapeutic area: Body processes [G] - Physical Phenomena [G01]
- Italy
- 2016-03-15
Authorised
- Modulation of Sympathetic Nerve Activity By Pioglitazone In Type 2 Diabetes Mellitus
- Type 2 diabetes mellitus
- United Kingdom
- 2005-02-17
Authorised
- A multi-centre, randomised, double-blind, placebo controlled, parallel group exploratory study to investigate the efficacy, safety and tolerability of AD 337 in the treatment of fibromyalgia in female subjects.
- Fibromyalgia
- United Kingdom
- 2006-03-03
Authorised
- increased efficacy of lidocaine when amitriptyline is added for local anaesthesia
- The objective of the present study is to investigate whether a combination of ultra-low-dose amitriptyline with the conventional local anesthetic lidocaine enhances the anesthetic effect of the latter via pharmacologic synergy. MedDRA version: 8.1 Level: LLT Classification code 10002095 Term: Anaesthesia local
- Austria
- 2007-07-04
